If American consumers got consistently excellent outcomes and high patient satisfaction in return for our high healthcare spending, we might consider this spending to be a “good value.” However, when comparing outcomes in the U.S. to other industrialized countries, the evidence shows a mixed bag. The U.S. is doing relatively well in some areas—such as cancer care—and less well in others—such as mortality from treatable and preventable conditions.
There are numerous aspects of healthcare quality that need to be addressed:
Aligning the priority quality objectives across payers and other stakeholders
Making quality transparent in a way that is actionable for consumers